188 related articles for article (PubMed ID: 30296193)
1. Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content.
Revilla N; Corral J; Miñano A; Mingot-Castellano ME; Campos RM; Velasco F; Gonzalez N; Galvez E; Berrueco R; Fuentes I; Gonzalez-Lopez TJ; de la Morena-Barrio ME; Gonzalez-Porras JR; Vicente V; Lozano ML
Platelets; 2019; 30(6):743-751. PubMed ID: 30296193
[TBL] [Abstract][Full Text] [Related]
2. Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia.
Mahévas M; Gerfaud-Valentin M; Moulis G; Terriou L; Audia S; Guenin S; Le Guenno G; Salles G; Lambotte O; Limal N; Viallard JF; Cheze S; Tomowiak C; Royer B; Neel A; Debouverie O; Hot A; Durieu I; Perlat A; Cliquennois M; Deteix C; Michel M; Godeau B
Blood; 2016 Sep; 128(12):1625-30. PubMed ID: 27354722
[TBL] [Abstract][Full Text] [Related]
3. Increased GPIbα shedding from platelets treated with immune thrombocytopenia plasma.
Wei G; Luo Q; Wang X; Wu X; Xu M; Ding N; Zhao Y; Zhong L; Wang J; Wu Y; Li X; Liu Y; Ju W; Li Z; Zeng L; Xu K; Qiao J
Int Immunopharmacol; 2019 Jan; 66():91-98. PubMed ID: 30445311
[TBL] [Abstract][Full Text] [Related]
4. New insights into the glycobiology of immune thrombocytopenia.
Tiemeyer KH; Kuter DJ; Cairo CW; Hollenhorst MA
Curr Opin Hematol; 2023 Nov; 30(6):210-218. PubMed ID: 37526945
[TBL] [Abstract][Full Text] [Related]
5. Platelet and immune characteristics of immune thrombocytopaenia patients non-responsive to therapy reveal severe immune dysregulation.
Monzón Manzano E; Álvarez Román MT; Justo Sanz R; Fernández Bello I; Hernández D; Martín Salces M; Valor L; Rivas Pollmar I; Butta NV; Jiménez Yuste V
Br J Haematol; 2020 Jun; 189(5):943-953. PubMed ID: 31945798
[TBL] [Abstract][Full Text] [Related]
6. Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia.
Alvarez Román MT; Fernández Bello I; Arias-Salgado EG; Rivas Pollmar MI; Jiménez Yuste V; Martín Salces M; Butta NV
Thromb Haemost; 2014 Jul; 112(1):65-72. PubMed ID: 24500066
[TBL] [Abstract][Full Text] [Related]
7. [Management of multirefractory immune thrombocytopenia].
Mahévas M; Audia S; Viallard JF
Rev Med Interne; 2021 Jan; 42(1):46-49. PubMed ID: 33334631
[TBL] [Abstract][Full Text] [Related]
8. Desialylation of platelets induced by Von Willebrand Factor is a novel mechanism of platelet clearance in dengue.
Riswari SF; Tunjungputri RN; Kullaya V; Garishah FM; Utari GSR; Farhanah N; Overheul GJ; Alisjahbana B; Gasem MH; Urbanus RT; de Groot PG; Lefeber DJ; van Rij RP; van der Ven A; de Mast Q
PLoS Pathog; 2019 Mar; 15(3):e1007500. PubMed ID: 30849118
[TBL] [Abstract][Full Text] [Related]
9. Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: an open-label, multicenter, randomized controlled trial.
Li MF; Li XL; Fan KL; Yu YY; Gong J; Geng SY; Liang YF; Huang L; Qiu JH; Tian XH; Wang WT; Zhang XL; Yu QX; Zhang YF; Lin P; Wang LN; Li X; Hou M; Liu LY; Peng J
J Hematol Oncol; 2017 May; 10(1):104. PubMed ID: 28494777
[TBL] [Abstract][Full Text] [Related]
10. Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopenia.
Tao L; Zeng Q; Li J; Xu M; Wang J; Pan Y; Wang H; Tao Q; Chen Y; Peng J; Hou M; Jansen AJ; Ni H; Zhai Z
J Hematol Oncol; 2017 Feb; 10(1):46. PubMed ID: 28179000
[TBL] [Abstract][Full Text] [Related]
11. CD8(+) T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia.
Qiu J; Liu X; Li X; Zhang X; Han P; Zhou H; Shao L; Hou Y; Min Y; Kong Z; Wang Y; Wei Y; Liu X; Ni H; Peng J; Hou M
Sci Rep; 2016 Jun; 6():27445. PubMed ID: 27321376
[TBL] [Abstract][Full Text] [Related]
12. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia.
Li J; van der Wal DE; Zhu G; Xu M; Yougbare I; Ma L; Vadasz B; Carrim N; Grozovsky R; Ruan M; Zhu L; Zeng Q; Tao L; Zhai ZM; Peng J; Hou M; Leytin V; Freedman J; Hoffmeister KM; Ni H
Nat Commun; 2015 Jul; 6():7737. PubMed ID: 26185093
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein Ibα clustering induces macrophage-mediated platelet clearance in the liver.
Yan R; Chen M; Ma N; Zhao L; Cao L; Zhang Y; Zhang J; Yu Z; Wang Z; Xia L; Ruan C; Dai K
Thromb Haemost; 2015 Jan; 113(1):107-17. PubMed ID: 25231551
[TBL] [Abstract][Full Text] [Related]
14. Effect of thrombopoietin-receptor agonists on circulating cytokine and chemokine levels in patients with primary immune thrombocytopenia (ITP).
Gudbrandsdottir S; Ghanima W; Nielsen CH; Feng X; Hasselbalch HC; Bussel J
Platelets; 2017 Jul; 28(5):478-483. PubMed ID: 27819522
[TBL] [Abstract][Full Text] [Related]
15. Chronic thrombocytopenia of childhood: use of non-invasive methods in clinical evaluation.
Rajantie J; Javela K; Joutsi-Korhonen L; Kekomäki R
Eur J Haematol; 2004 Apr; 72(4):268-72. PubMed ID: 15089765
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with oseltamivir phosphate in a patient with chronic immune thrombocytopenia positive for anti-GPIb/IX autoantibody.
Shao L; Wu Y; Zhou H; Qin P; Ni H; Peng J; Hou M
Platelets; 2015; 26(5):495-7. PubMed ID: 25166956
[TBL] [Abstract][Full Text] [Related]
17. Desialylation is associated with apoptosis and phagocytosis of platelets in patients with prolonged isolated thrombocytopenia after allo-HSCT.
Zhang XH; Wang QM; Zhang JM; Feng FE; Wang FR; Chen H; Zhang YY; Chen YH; Han W; Xu LP; Liu KY; Huang XJ
J Hematol Oncol; 2015 Oct; 8():116. PubMed ID: 26497387
[TBL] [Abstract][Full Text] [Related]
18. Platelet desialylation and TFH cells-the novel pathway of immune thrombocytopenia.
Chen Y; Hu J; Chen Y
Exp Hematol Oncol; 2021 Mar; 10(1):21. PubMed ID: 33722280
[TBL] [Abstract][Full Text] [Related]
19. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura.
Kosugi S; Kurata Y; Tomiyama Y; Tahara T; Kato T; Tadokoro S; Shiraga M; Honda S; Kanakura Y; Matsuzawa Y
Br J Haematol; 1996 Jun; 93(3):704-6. PubMed ID: 8652398
[TBL] [Abstract][Full Text] [Related]
20. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies.
Aledort LM; Hayward CP; Chen MG; Nichol JL; Bussel J;
Am J Hematol; 2004 Jul; 76(3):205-13. PubMed ID: 15224353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
